Barclays downgraded Keurig Dr Pepper (KDP) to Equal Weight from Overweight with a price target of $26, down from $39. While the company’s asset reshuffling could be the right move longer term, the transactions “present elevated noise and uncertainty over the next 12 months,” the analyst tells investors in a research note. Barclays is challenged to believe new information at Keurig’s investor event in October will serve as a positive catalyst “as there will be plenty to bear out over time.” It cites heightened complexity in the Keurig narrative near term for the downgrade.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper call volume above normal and directionally bullish
- Pfizer to acquire Metsera, Oracle names new CEOs: Morning Buzz
- Humana initiated, Paycom upgraded: Wall Street’s top analyst calls
- BNP downgrades Keurig Dr Pepper to Underperform after poorly received deal
- Keurig Dr Pepper downgraded to Underperform from Neutral at BNP Paribas Exane